[1] |
Copp AJ, Adzick NS, Chitty LS, et al. Spina bifida[J]. Nat Rev Dis Primers, 2015, 1: 15007.
|
[2] |
Adzick NS. Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention[J]. Semin Fetal Neonatal Med, 2010, 15(1): 9-14.
|
[3] |
Li Z, Ren A, Zhang L. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China[J]. Birth Defects Res A Clin Mol Teratol, 2006, 76(4): 237-240.
|
[4] |
Sahmat A, Gunasekaran R, Mohd-Zin SW, et al. The prevalence and distribution of spina bifida in a single major referral center in Malaysia[J]. Front Pediatr, 2017, 55: 237.
|
[5] |
Beyer DA, Diedrich K, Weichert J, et al. Seasonality of spina bifida in northern Germany[J]. Arch Gynecol Obstet, 2011, 284(4): 849-854.
|
[6] |
Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001[J]. Birth Defects Res A Clin Mol Teratol, 2006, 76(11): 747-756.
|
[7] |
Fauza DO, Jennings RW, Teng YD, et al. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida[J]. Surgery, 2008, 144(3): 367-373.
|
[8] |
王维.叶酸的绿色合成工艺研究[D].南京:东南大学, 2016.
|
[9] |
Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects[J]. Am J Med Genet C Semin Med Genet, 2005, 135C(1): 9-23.
|
[10] |
Zhang T, Lou J, Zhong R, et al. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature[J]. PLoS One, 2013, 8(4): e59570.
|
[11] |
Mohd-Zin SW, Marwan AI, Abou C, et al. Spina bifida: pathogenesis, mechanisms, and genes in mice and humans[J]. Scientifica, 2017, 2017: 5364827.
|
[12] |
Atta CA, Fiest KM, Frolkis AD, et al. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis[J]. Am J Public Health, 2016, 106(1): e24-e34.
|
[13] |
Blomberg MI, Källén B. Maternal obesity and morbid obesity: the risk for birth defects in the offspring[J]. Birth Defects Res A Clin Mol Teratol, 2010, 88(1): 35-40.
|
[14] |
Carmichael SL, Rasmussen SA, Shaw GM. Prepregnancy obesity: a complex risk factor for selected birth defects[J]. Birth Defects Res A Clin Mol Teratol, 2010, 88(10): 804-810.
|
[15] |
Stothard KJ, Tennant PWG, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis[J]. JAMA, 2009, 301(6): 636-650.
|
[16] |
Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women[J]. Trends Endocrinol Metab, 2001, 12(2): 78-82.
|
[17] |
Davidson CM, Northrup H, King TM, et al. Genes in glucose metabolism and association with spina bifida[J]. Reprod Sci, 2008, 15(1): 51-58.
|
[18] |
Murdoch JN, Damrau C, Paudyal A, et al. Genetic interactions between planar cell polarity genes cause diverse neural tube defects in mice[J]. Dis Model Mech, 2014, 7(10): 1153-1163.
|
[19] |
Keller R. Shaping the vertebrate body plan by polarized embryonic cell movements[J]. Science, 2002, 298(5600): 1950-1954.
|
[20] |
Goodrich LV, Strutt D. Principles of planar polarity in animal development[J]. Development, 2011, 138(10): 1877-1892.
|
[21] |
Veeman MT, Slusarski DC, Kaykas A, et al. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements[J]. Curr Biol, 2003, 13(8): 680-685.
|
[22] |
Tada M, Smith JC. Xwnt11 is a target of xenopus brachyury: regulation of gastrulation movements via dishevelled, but not through the canonical Wnt pathway[J]. Development, 2000, 127(10): 2227-2238.
|
[23] |
Allache R, De Marco P, Merello E, et al. Role of the planar cell polarity gene CELSR1 in neural tube defects and caudal agenesis[J]. Birth Defects Res A Clin Mol Teratol, 2012, 94(3): 176-181.
|
[24] |
Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects[J]. Hum Mol Genet, 2009, 18(R2): R113-R129.
|
[25] |
Harris MJ. Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants[J]. Birth Defects Res A Clin Mol Teratol, 2009, 85(4): 331-339.
|
[26] |
Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects[J]. Dev Disabil Res Rev, 2010, 16(1): 6-15.
|
[27] |
Radbruch A, Isaacs J. Animal models in infection and inflammation-chance and necessity[J]. Eur J Immunol, 2010, 39(8): 1991-1993.
|
[28] |
Meuli M, Meuli-Simmen C, Yingling CD, et al. Creation of myelomeningocele in utero: a model of functional damage from spinal cord exposure in fetal sheep[J]. J Pediatr Surg, 1995, 30(7): 1028-1032.
|
[29] |
Meuli M, Meuli-Simmen C, Hutchins GM, et al. In utero surgery rescues neurological function at birth in sheep with spina bifida[J]. Nature Medicine, 1995, 1(4): 342-347.
|
[30] |
Adzick NS. Fetal surgery for spina bifida: past, present, future[J]. Semin Pediatr Surg, 2013, 22(1): 10-17.
|
[31] |
Adzick NS. Fetal surgery for myelomeningocele: trials and tribulations. Isabella Forshall Lecture[J]. J Pediatr Surg, 2012, 47(2): 273-281.
|
[32] |
Inversetti A, Van der Veeken L, Thompson D, et al. Neurodevelopmental outcome of children with spina bifida aperta repaired prenatally vs postnatally: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2019, 53(3): 293-301.
|
[33] |
Papanna R, Moise KJ Jr, Mann LK, et al. Cryopreserved human umbilical cord patch for in-utero spina bifida repair[J]. Ultrasound Obstet Gynecol, 2016, 47(2): 168-176.
|
[34] |
Mann LK, Won JH, Trenton NJ, et al. Cryopreserved human umbilical cord versus acellular dermal matrix patches for in utero fetal spina bifida repair in a pregnant rat model[J]. J Neurosurg Spine, 2019, 32(2): 321-331.
|
[35] |
Sacco A, Van der Veeken L, Bagshaw E, et al. Maternal complications following open and fetoscopic fetal surgery: a systematic review and meta-analysis[J]. Prenat Diagn, 2019, 39(4): 251-268.
|
[36] |
Pedreira DA, Reece EA, Chmait RH, et al. Fetoscopic repair of spina bifida: safer and better?[J]. Ultrasound Obstet Gynecol, 2016, 48(2): 141-147.
|
[37] |
Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details[J]. Cell Stem Cell, 2009, 4(3): 206-216.
|
[38] |
Prockop DJ, Kota DJ, Bazhanov N, et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs)[J]. J Cell Mol Med, 2010, 14(9): 2190-2199.
|
[39] |
Li H, Gao F, Ma L, et al. Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta[J]. J Cell Mol Med, 2012, 16(7): 1606-1617.
|
[40] |
Bamba Y, Nonaka M, Sasaki N, et al. Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with spina bifida aperta[J]. Asian Spine J, 2017, 11(6): 870-879.
|
[41] |
Okano H, Nakamura M, Yoshida K, et al. Steps toward safe cell therapy using induced pluripotent stem cells[J]. Circ Res, 2013, 112(3): 523-533.
|